You are here
Stephen del Cardayre
Stephen del Cardayre is responsible for research and development at REG Life Sciences. Prior to joining REG Life Sciences, Dr. del Cardayre spent seven and a half years at LS9, Inc. (acquired by REG in 2014) where he was a founding member of the company. Prior to LS9, Dr. del Cardayre spent nine years at Codexis and Maxygen, where he was directly involved in the development, application and commercialization of technologies for the engineering of biocatalytic processes for the pharmaceutical and chemical industry. Dr. del Cardayre has published extensively on the engineering of biological systems, focusing primarily on the engineering of enzyme and whole cell biocatalysts.
By training, Dr. del Cardayre is a biochemist, receiving an undergraduate degree in Biochemistry from the University of California - Berkeley, a Ph.D. in Biochemistry from the University of Wisconsin-Madison, and Post doctoral training in Microbial Biotechnology at the University of British Columbia.